aluminoxamine has been researched along with Uremia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ionova, D; Kambova, L; Kirijakov, Z | 1 |
| Andriani, M; Nordio, M; Saporiti, E | 1 |
| Blanco-González, E; Cannata-Andía, JB; Fernández-Martín, JL; Menéndez-Fraga, P | 1 |
| Arnaud, A; Bongiorno, P; Caligaris, F; Canavese, C; Cardelli, R; D'Amicone, M; Gurioli, L; Marchiori, M; Mattiello, G | 1 |
4 other study(ies) available for aluminoxamine and Uremia
| Article | Year |
|---|---|
Aluminium overload influences cognitive function in patients on dialysis.
Topics: Adult; Aluminum; Brain Diseases; Chelating Agents; Cognition; Deferoxamine; Female; Humans; Male; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1994 |
Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients.
Topics: Aluminum; Antidotes; Chelating Agents; Data Interpretation, Statistical; Deferoxamine; Drug Administration Schedule; Ferric Compounds; Hemosiderosis; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1996 |
Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.
Topics: Aluminum; Chelating Agents; Chromatography, High Pressure Liquid; Deferoxamine; Ferric Compounds; Humans; Organometallic Compounds; Renal Dialysis; Spectrophotometry, Atomic; Time Factors; Uremia | 1998 |
Kinetics of aluminoxamine and feroxamine chelates in dialysis patients.
Topics: Adult; Aged; Aluminum; Chelating Agents; Deferoxamine; Humans; Iron; Kinetics; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1992 |